Sulfonylureas and Meglitinides

Author: Judy Kohn, RN, BSN, CDE
Last Updated: Wednesday, February 22, 2006

Q: "I am only on Glucophage® but my blood glucose is not in target range and my doctor said he plans to add a sulfonylurea. Would you explain more about sulfonylureas?"

A: With all the different types of diabetes medications available to people with type 2 diabetes, it is hard to keep up with all of them.

First, a quick review:

How insulin works-it has 3 main roles:

3 Defects in Type 2 Diabetes That can be Targeted by Oral Agents:

  1. Insulin resistance: In essence, the body is unable to use insulin effectively. I explain in the related question below that "it is as if there aren't enough doors on the cell wall, or the doors are stuck, or the lock has been changed, or else once the glucose gets into the cell it doesn't know what to do."
  2. Increased glucose production by the liver: Usually, as soon as you begin eating, insulin tells the liver to "shut its door" and to quit releasing glucose, since you can now get glucose from the food you're eating. With diabetes, the liver doesn't shut off, so it continues to produce unnecessary glucose.
  3. Decreased insulin production: Eventually, as diabetes progresses, the pancreas loses its ability to produce enough insulin-either it is delayed in releasing insulin, or it can't make enough-affectionately called a "pooped out pancreas."

How Sulfonylureas and Meglitinides Work

Both sulfonylureas and meglitinides address the 3rd bulleted defect listed above-that is, they stimulate the pancreas to produce more insulin. Both drugs have the potential to cause hypoglycemia although reports are that people taking meglitinides have a lower risk of hypoglycemia due to the shorter duration of these drugs.

Side Effects:

As mentioned above, the main side effect would be the risk of hypoglycemia, if your dose were too high, if you delayed or skipped a meal or ate less than usual, if you had alcohol without adequate food, or if you did unexpected activity.

Other effects or interactions:

Because there are many different brand names of drugs in these categories, there might be other effects or different drug interactions with each one, so it is best to discuss your individual drug with both your doctor and your pharmacist. But in general, these drugs are considered safe and well tolerated by most people.

Combining sulfonylureas or meglitinides with other diabetes drugs:

Due to the 3 defects in type 2 diabetes, it is common that you may eventually require more than one category of diabetes medication. Studies show that when needed, combining 2 or more diabetes pills with different mechanisms of action can be very effective.

Conclusion:

Finally, just as you know there is "no free lunch", remember that meal planning, regular activity, and glucose monitoring are still the cornerstones of good diabetes management, and that diabetes pills are another tool to help you keep your diabetes in good control.

Be sure to discuss all your medications, side effects, safety precautions, and possible interactions with your physician.


Related Questions

Glucophage®
Q: "Can you explain to me how Glucophage® XR works? I have lost 14 pounds since being diagnosed and I am successfully keeping my blood sugar under control by counting carbs. I am supposed t..."

Hypoglycemic Reaction
Q: "I've been diagnosed as type 2 since March of this year with a BG of 547 (I had infections). I take one 10 mg Glucotrol in the morning and one 500 mg Metformin in the morning and one in the afternoon. ..."

Long-term effects of oral agents
Q: "I currently take Avandia® 4mg twice daily and Glucophage® 850mg twice daily. My typical fasting is 120. My question is: What are the long-term effects of the two drugs I ..."

Insulin Resistance
Q: "Could you explain insulin resistance so that I can understand it? This term seems confusing to me."

Combination Pills
Q: "Are the combination pills, such as Avandamet®, Glucovance® and Metaglip® better than taking the individual pills?"


Related Links

American Diabetes Association (ADA)
http://www.diabetes.org

Diabetes Self-Management
http://www.diabetesselfmanagement.com

National Diabetes Information Clearinghouse (NDIC)
http://diabetes.niddk.nih.gov

Novo Nordisk Inc.: "PRANDIN® (repaglinide) Tablets"
http://www.prandin.com

Novartis Pharmaceuticals Corporation: "STARLIX® (nateglinide) Tablets"
http://www.starlix.com


 

Important Notice: The responses provided by the team of Diabetes Educators are based on their personal experiences and expertise as practicing diabetes healthcare professionals, and are not to be considered diabetes management advice from Abbott Laboratories. Remember that information provided by the team of Diabetes Educators is for general background purposes and is not intended as a substitute for medical diagnosis or treatment by a trained professional. You should always consult your physician about any healthcare questions you may have, especially before trying a new medication, diet, fitness program, or approach to healthcare issues.

All tradenames and trademarks not owned by Abbott Laboratories are the property of their respective owners. For details on tradenames and trademarks and their respective owners, visit the non-Abbott trademarks listing.

DOC09483-Rev-A 01/07